Bimekizumab Tops Secukinumab for Plaque Psoriasis

MONDAY, April 26, 2021 -- For patients with moderate-to-severe plaque psoriasis, bimekizumab is noninferior and superior to secukinumab and adalimumab, according to two studies published online April 23 in the New England Journal of Medicine to...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news